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A B S T R A C T
The aim of this study was to show how different coping mechanisms influence the prevalence of anxiety and depres-
sion in people suffering from multiple sclerosis. We also aimed at showing how different coping mechanisms contribute
to subjective prosperity of the patients emphasizing general health, cognitive functions and fatigue. A questionnaire was
given to attendants of the VI Symposium of Patients Suffering FromMultiple Sclerosis. Scales were taken fromMultiple
Sclerosis Quality of Life Inventory (MSQLI), Hospital Anxiety and Depression Scale (HADS) and COPE inventory. A to-
tal of 68 anonymous questionnaires were handed in. A total of 57.9% of examinees had symptoms of depression, and
63.2% suffered from symptoms of anxiety. However, majority of the examinees suffered from the combination of these en-
tities. Hypothesis about impact of various coping factors on depression, anxiety, fatigue was validated except an impact
on physical state was not proven significant. Predictors improving these states were positive reinterpretation, social emo-
tional support and humor, Predictors worsening these states were planning, acceptance, focus on emotional ventilation
and denial. Psychiatric comorbidity has a high prevalence in people suffering from MS. Different coping mechanisms
can help in improvement of everyday life.
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Introduction
Multiple sclerosis is a chronic demyelization disease
of central nervous system leading to various focal neuro-
logical deficits. This disease is characterized by unpre-
dictable and mutilating progression towards invalidity.
Higher prevalence of psychiatric disorders in this group
of patients has been confirmed by numerous studies1–3.
But this problem has been underestimated in medical re-
search and everyday clinical practice. Even the British
Medical Journal editorial »Multiple sclerosis, depression,
suicide: clinicians should pay more attention to psy-
chopathology« has stated several concerns about little
progress being made in this area of multiple sclerosis4.
There are two major proposed mechanisms of patho-
genesis of psychiatric disorders in multiple sclerosis.
First theory proposes that depression and anxiety are di-
rect consequence of disease’s activity; therefore these
disorders are caused by demyelization lesions in certain
areas of brain. Several authors have suggested that left
frontal and temporal lesions and global atrophy of gray
and white matter contributes to development of psychi-
atric comorbidity in multiple sclerosis5–6. These studies
show only preliminary data and were carried on small
sample of patients suffering from multiple sclerosis, the-
refore evidence for demyelization pathogenesis of depres-
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sion is somewhat scarce. Second theory implies that psy-
chiatric comorbiditiy is a result of maladaptive reaction
to the disease. The individual diagnosed with multiple
sclerosis is facing invalidity, social deterioration and as a
consequence to dire social, psychological and physical
changes is at higher risk of developing anxiety and mood
disorders. Multiple sclerosis due to its relapsing and
chronic course causes high number of stressful life events
leading to susceptibility to these psychiatric disorders.
The main purpose of this study is to evaluate the role
of various coping mechanism in psychiatric comorbidity
in patients suffering from multiple sclerosis. We hypoth-
esize that certain maladaptive coping mechanisms such
as denial or avoidance are used by individuals suffering
from depressive and anxiety disorders and, therefore,
this coping strategies could have a role in pathogenesis of
psychiatric disorders in this population. Other objects of
our study are to show the connection of various mala-
daptive coping mechanisms with other multiple sclerosis
symptoms such as fatigue, cognitive deficits and physical
health.
Subjects and Methods
The questionnaire was given to the attendants of VIth
Symposium of Individuals Suffering from Multiple Scle-
rosis. 150 participants were randomly chosen and given
the questionnaire to fill in. 68 subjects responded. The
testing was anonymous. There was no possibility of re-
viewing their medical data or performing neurological
examination. 75.7% of participants were female, 14.7%
male, for other the sex is unknown. Male to female ratio
is 5:1 which is consistent with current epidemiological
data for multiple sclerosis in Croatia7. We divided sub-
jects in three different age groups; first group consisting
of subjects 20–29 years old, second group including sub-
jects 30–55 years old and third group consisting of sub-
jects 56–80 years old. As expected, majority of subjects
(63.2%) belonged to second group which is consistent
with multiple sclerosis epidemiological data.
The questionnaire consisted of 150 questions. The
first part was general questionnaire in other to acquire
basic social and demographic data; age, sex, age of diag-
nosis, education etc. Second part included several psy-
chometric taken from Multiple Sclerosis Quality of Life
Inventory8. These scales were Health Status (SF36),
Modified Fatigue Impact Scale (MFIS) and Perceived
Deficits Questionnaire (PDQ). SF36 questionnaire as-
sesses 8 dimensions of health, varying from physical
roles to mental health. It was derived from General
Health Survey of the Medical Outcomes Study9 and mod-
ified for multiple sclerosis population. It consists of 31
items and 8 various subscales. MFIS measures an impact
of fatigue on everyday life in multiple sclerosis and vari-
ous subscales of fatigue such as physical, psychosocial
and cognitive fatigue. MFIS consisting of 21 items has a
range of score from 21 to 105 points. Cutoff values for
this scale do not exist. The higher score signifies the
greater impact of fatigue on subject’s activities. PDQ is a
measure assessing self reported cognitive deficits varying
from concentration to retrospective and prospective me-
mory. It consists of 20 items. Score ranges from 20 to 100,
with higher score signifying the greater perceived cogni-
tive dysfunctions. Third part consisted of Hospital Anxi-
ety and Depression Scale10 (HADS), a psychometric in-
strument used to detect depression and anxiety disor-
ders. It consists of 14 items, 7 items for anxiety and 7
items for depression. Total score for each subscale ranges
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TABLE 1
DESCRIPTIVE DATA ABOUT COPE MECHANISM USED BY MULTIPLE SCLEROSIS PATIENTS
Coping mechanisms X SD C D v Range Min Max
Positive reinterpretation and growth 13.27 1.88 14.00 14.00 3.53 8.00 8.00 16.00
Mental disengagement 10.67 2.51 11.00 9.00 6.30 12.00 4.00 16.00
Focus and venting of emotions 11.88 2.32 12.50 13.00 5.40 8.00 8.00 16.00
Use of instrumental social support 11.92 2.55 12.00 13.00 6.54 10.00 6.00 16.00
Active coping 12.52 1.76 12.00 12.00 3.11 8.00 8.00 16.00
Denial 9.50 2.92 10.00 10.00 8.53 12.00 4.00 16.00
Religious coping 12.25 4.83 13.50 16.00 23.29 25.00 4.00 29.00
Humor 11.73 2.60 12.00 12.00 6.79 11.00 5.00 16.00
Behavioral disengagement 9.67 2.80 10.00 10.00 7.87 12.00 4.00 16.00
Restraint 11.47 2.38 12.00 13.00 5.68 10.00 6.00 16.00
Use of emotional social support 11.57 2.83 12.00 13.00 8.06 12.00 4.00 16.00
Substance use 6.94 2.20 6.00 6.00 4.84 12.00 4.00 16.00
Acceptance 13.44 2.49 14.00 16.00 6.21 10.00 6.00 16.00
Suppression of competing activities 10.71 2.36 11.00 9.00 5.61 11.00 5.00 16.00
Planning 12.62 2.40 13.00 14.00 5.78 10.00 6.00 16.00
X – mean, SD – standard deviation, C – central value, D – dominant value, v – variance, Min – minimal value, Max – maximal value
from 0 to 21. Subjects, who score from 8 to 12 points, suf-
fer from borderline mood disorder, and those who score
above 12 points have definitely acquired either depres-
sion or anxiety or both. Last part consisted of COPE in-
ventory, a questionnaire used to measure the use of vari-
ous cope strategies. It consists of 14 various scales (each
having 4 items, 56 items in total) measuring different
coping mechanisms (Table 1). There are no cutoff values
for each scale. Subjects were instructed to describe their
cope mechanisms concerning multiple sclerosis and all
stressful situations as a result from the disease.
After all data was collected, basic descriptive data was
derived. To test our hypothesis of various cope mecha-
nisms as predictor variables of scores on Hospital Anxi-
ety and Depression Scale, Modified Fatigue Impact Scale,
Perceived Deficits Questionnaire and Health Status Que-
stionnaire, multiple regression analysis was performed.
All statistical analyses were performed with the Statisti-
cal Package for Social Sciences for Windows, ver. 15.0
(SPSS Inc., Chicago, IL, USA). The level of statistical dif-
ference was set at p<0.05 or p<0.001, as indicated.
Results
Basic descriptive data of usage of different cope strat-
egies is shown in table 1. Subjects have highest score in
these subscales: »acceptance« (mean [X]=13.27, stan-
dard deviation [SD]=1.88), »positive reinterpretation and
growth« (X=13.27, SD=1.88).Generally, there is no pre-
dominating cope strategy used by subjects. Furthermore,
subjects seem to employ both problem-focused and emo-
tion-focused cope mechanisms equally. In reviewing these
results, it must be accounted that no specific cut off score
for COPE inventory exists.
The frequencies of depression and anxiety measured
by HADS are shown in Table 2. Only 29.80% of subjects
do not show symptoms of anxiety nor depression, with
majority of subjects (50.9%) showing the symptoms of
both affective and anxiety spectrum disorders. None of
the subjects suffers from isolated depression. In average,
subjects have scored more on anxiety (X=9.14, SD=
4.83) than on depression subscale (X=8.12, SD=4.32)
with maximum score on each subscale of 20.
Several coping strategies have been identified as predi
ctor variables for depression as shown in Table 3. These
are »positive reinterpretation and growth« (B=–0.90;
p=0.030), »humor« (B=–0.76; p=0.015) and »religious
coping« (B=0.61; p= 0.015).With this set of predictors
65.8% of variance of depression was explained (R2=0.658).
The hypothesis on impact of various cope mechanisms on
depression was confirmed.
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TABLE 2
FREQUENCIES OF DEPRESSIVE AND ANXIETY
DISORDERS IN MS PATIENTS
Depression
Anxiety
TotalDo not
suffer from
Borderline
Suffer
from
Do not
suffer from
17
(29.80%)
5
(8.80%)
2
(3.50%)
24
(42.10%)
Borderline
4
(7.00%)
6
(10.50%)
7
(12.30%)
17
(29.80%)
Suffer from
0
(0.00%)
1
(1.80%)
15
(26.30%)
16
(28.10%)
Total
21
(36.80%)
12
(21.10%)
24
(42.10%)
57
(100.00%)
TABLE 3
COPING MECHANISMS AS PREDICTOR VARIABLES OF DEPRESSION
Coping mechanisms B SE b t p
Positive reinterpretation and growth –0.90 0.39 –0.38 –2.33 0.030*
Mental disengagement –0.03 0.29 –0.02 –0.12 0.908
Focus and venting of emotions 0.00 0.30 0.00 0.00 0.996
Use of instrumental social support 0.05 0.41 0.03 0.12 0.904
Active coping –0.08 0.62 –0.03 –0.12 0.904
Denial 0.39 0.28 0.28 1.40 0.177
Religious coping 0.01 0.19 0.01 0.06 0.955
Humor –0.76 0.29 –0.49 –2.64 0.015*
Behavioral disengagement 0.15 0.26 0.10 0.56 0.584
Restraint –0.25 0.43 –0.13 –0.59 0.563
Use of emotional social support –0.36 0.28 –0.24 –1.29 0.212
Substance use 0.21 0.41 0.11 0.51 0.615
Acceptance 0.67 0.34 0.35 1.94 0.065
Suppression of competing activities –0.32 0.43 –0.16 –0.74 0.465
Planning 0.61 0.31 0.35 1.97 0.062
*statistical significance at level p<0.05
In Table 4, coping mechanisms as predictors of anxiety
are shown. Five predictors were statistically significant;
»denial« (B=0.54; p=0.050), »humor« (B=–0.58; p=0.048),
»behavioral disengagement« (B=0.63; p=0.019), »planning«
(B=0.58; p=0.048).Whole set of predictors explained the
74.8% of variance (R2=0.748). The hypothesis on connec-
tion between cope strategies and anxiety was confirmed.
Subjects averagely scored 70.03 points (SD=10.26),
and 50% of subjects scored more than 71 points on MFIS.
This score signifies high impact of fatigue in this group.
After multiple regression analysis, three cope mechani-
sms were proven to be statistically significant: »positive
reinterpretation and growth« (B=–3.17; p= 0.009), hu-
mor (B=–2.83, p=0.003) and »acceptance« (B=1.92; p=
0.046). Whole set of predictors, as shown in Table 5, ex-
plains 66.4% of variance (R2=0.650).
Average score on PDQ was X=52.42, with 50% sub-
jects scoring more than 52. Although no cutoff values are
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TABLE 4
COPING MECHANISMS AS PREDICTOR VARIABLES OF ANXIETY
Coping mechanisms B SE b t p
Positive reinterpretation and growth –0.22 0.37 –0.09 –0.61 0.548
Mental disengagement –0.18 0.28 –0.10 –0.67 0.512
Focus and venting of emotions 0.37 0.28 0.19 1.31 0.205
Use of instrumental social support –0.35 0.39 –0.19 –0.91 0.374
Active coping 0.21 0.62 0.07 0.33 0.741
Denial 0.54 0.26 0.36 2.06 0.050
Religious coping 0.11 0.18 0.08 0.57 0.572
Humor –0.58 0.28 –0.35 –2.10 0.048*
Behavioral disengagement 0.63 0.25 0.40 2.54 0.019*
Restraint –0.22 0.41 –0.11 –0.55 0.590
Use of emotional social support –0.53 0.26 –0.33 –2.02 0.057
Substance use –0.11 0.39 –0.06 –0.29 0.778
Acceptance 0.46 0.33 0.22 1.40 0.175
Suppression of competing activities –0.18 0.40 –0.09 –0.44 0.661
Planning 0.58 0.29 0.31 1.98 0.048*
*statistical significance at level p<0.05
TABLE 5
COPING MECHANISM AS PREDICTOR VARIABLES OF FATIGUE
Coping mechanisms B SE b t p
Positive reinterpretation and growth –3.17 1.13 –0.40 –2.79 0.009**
Mental disengagement –0.30 0.90 –0.05 –0.34 0.734
Focus and venting of emotions 0.89 0.94 0.14 0.95 0.347
Use of instrumental social support 0.17 1.18 0.02 0.14 0.885
Active coping –2.39 1.67 –0.26 –1.40 0.163
Denial 1.23 0.82 0.25 1.49 0.147
Religious coping 0.41 0.46 0.11 0.88 0.384
Humor –2.83 0.88 –0.52 –3.20 0.003**
Behavioral disengagement 0.80 0.76 0.15 1.05 0.299
Restraint 0.57 1.18 0.09 0.48 0.631
Use of emotional social support –0.32 0.84 –0.06 –0.38 0.706
Substance use –1.46 1.17 –0.22 –1.25 0.221
Acceptance 1.92 0.91 0.33 2.09 0.046*
Suppression of competing activities 1.72 1.15 0.28 1.48 0.149
Planning 1.55 0.97 0.26 1.59 0.123
*statistical significance at level p<0.05; **statistical significance at level p<0.01
available, it can be concluded that a high level of self re-
ported cognitive deficits exists in this group. Several cope
strategies were statistically significant; focus on and ven-
tilation of emotions (B=1.99; p<0.05), use of emotional
social support (B =–2.87; p<0.05) and planning (B =2.71;
p<0.05). Whole set of predictors explain 65% of variance
(R2=0.650).
After multiple regression analysis, significant predic-
tors for subscales describing the physical status of status
were not found. Only for vitality scale and mental health
there were statistically significant predictor variables.
Discussion
Traditionally, coping strategies are divided in two
mayor groups: problem-focused coping and emotion-fo-
cused coping12. The use of specific mechanism highly de-
pends on the stressor itself and use of emotion-focused
coping is often connected with disease-related stressors.
Although some authors suggest that coping toward mul-
tiple sclerosis-related stressors is generally emotion-fo-
cused13, our study suggests that both types of mechanisms
are expressed in this population, although this distinc-
tion is sometimes too simplicistic11 not emphasizing the
importance of adaptive/maladaptive cope strategies.
Other studies report using structured psychiatric in-
terviews similar occurrence of depressive symptoms14–16
to our results. We could have overestimated the occur-
rence of depression and anxiety due to use of HADS, al-
though goal of this study is not to estimate prevalence of
mood disorder in multiple sclerosis. Major advantage of
the study is that our subjects form community sample
unlike most of other studies. Similar results were ob-
tained for anxiety using HADS in a study by Smith et
al.17. This study confirms the significance of psychiatric
comorbidity in MS population leading to a suicide rates
7.5 higher than in normal population18.
Planning as clearly problem-focused cope mechanism
leading to active coping has been connected with both de-
pressive and anxiety symptoms and is obviously ma-
ladaptive in MS subjects. The reason for this remains un-
known. Authors propose that the mutilating effect of
multiple sclerosis abrupt the process of execution of
strategies mentally planned, therefore leading to reac-
tive frustrations and feeling of self helplessness increas-
ing the chance of developing the mood or anxiety disor-
der. The use of humor as emotion-focused mechanism
has shown to be protective for subjects against depres-
sion, anxiety and fatigue clearly being one of the most
adaptive cope strategies in this population. This mecha-
nism could be used in been shown to be protective cope
mechanism against anxiety and fatigue. Through sec-
ondary reappraisal, this strategy leads to active coping
and reduction of stress, therefore reduces the level of de-
pressive symptoms. Our study has indirectly shown through
similar cope strategies connection between depression
and multiple sclerosis fatigue. It is important to state
that some aspects of fatigue in this population may be
contributed to mood disorder, although the pathogenesis
of fatigue remains unknown as confirmed in other
studies19,20. The importance of cope strategies in fatigue
has also been confirmed by finding significant predictors
of vitality, an independent measure of fatigue. In most of
fatigue syndromes cognitive-behavioral therapy chang-
ing maladaptive cope strategies towards adaptive was
found beneficial, although no study was performed in
treatment of multiple sclerosis fatigue21. Surprisingly,
denial was connected only to the anxiety as a significant
predictor, neither to the depression nor fatigue. Univer-
sally, these cope mechanism is found as maladaptive
leading to absence of active coping through the mecha-
nism of denying of the existence of the stressor. Also, a
mechanism opposite of denial, acceptance was found to
be connected with fatigue. PDQ scale by some authors
has lower correlation with objective neuropsychological
scale, but this questionnaire can also be used to evaluate
the role of depression on cognitive deficits8. By DSM
VI22psychomotoric retardation is one of the criteria for
MDD, and therefore PDQ scale could be used to assess
this issue. We found several significant predictors con-
nected to cognitive dysfunction; focus on emotions and
planning while use of emotional social support was pro-
tective. Surprisingly, two major emotions focused coping
mechanism are connected with cognitive deficits. Lack of
objective neuropsychological testing disables this study
of making connection assumptions about connection be-
tween cognitive deficits and cope strategies.
Furthermore, this is yet another study which con-
firms lack of association between cope mechanisms and
physical scale. Though we used self reported question-
naire SF36, a particular subscale »role physical« correla-
tes well with Extended Disability Status Scale (EDSS)8,23,24.
This has been validated by some studies, although there
are contradictory data in this research field25–27. We con-
clude that probably coping mechanism do not exert their
effects on neurological dysfunction in patients suffering
from multiple sclerosis, although that does not diminish
their importance in this disorder. Furthermore, several
authors have connected that higher number of everyday
stressors increase the number of relapse and that several
cope mechanisms such as the use of emotional social sup-
port decreases the number of relapses28,29.
As shown in this study, coping mechanisms are associ-
ated with depression, anxiety and fatigue in multiple
sclerosis. The use of this approach could serve well in
cognitive behavioral therapy of these patients. This study
emphasizes that switch from maladaptive cope mecha-
nisms to adaptive ones such as humor, positive reinter-
pretation and growth or use of emotional social support.
It is interesting that most of »problem focused« strate-
gies haven’t proven to be beneficial in psychiatric co-
morbidity and psychological distress perhaps due to a
fact that multiple sclerosis is constant stressor. Further-
more, it points that cognitive behavioral therapy could be
used more often in dealing with multiple sclerosis pa-
tients to reduce the psychiatric comorbidity. The need for
further research in this area is obvious, but still remains
somewhat scarce. In one meta-analysis on effective treat-
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ment of mood disorders in multiple sclerosis, only five
studies were eligible to enter with final results showing
that cognitive-behavioral therapy focused on appropriate
coping skills remains the treatment of choice30.
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POVEZANOST IZME\U MEHANIZMA SUO^AVANJA, DEPRESIJE, TJESKOBE I OSJE]AJA
UMORA KOD PACIJENATA OBOLJELIH OD MULTIPLE SKLEROZE
S A @ E T A K
Cilj ovog rada bio je prikazati kako razli~iti mehanizmi suo~avanja utje~u na psihofizi~ko stanje (umor, kognitivne
disfunkcije, op}e fizi~ko i emocionalno stanje) te na pojavu anksioznih i depresivnih poreme}aja u bolesnika koji boluju
od multiple skleroze. Upitnik koji se sastojao od ljestvica preuzetih iz Multiple Sclerosis Quality of Life Inventory (MSQLI),
Hospital Anxiety and Depression Scale (HADS) i COPE inventory, podijeljen je sudionicima VI. Simpozija oboljelih od
multiple skleroze. Vra}eno je 68 anonimno ispunjenih upitnika.Ukupno 57,9% ispitanika pati od simptoma depresije, a
63,2% uzorka ima simptome anksioznosti. Dokazana je hipoteza o utjecaju razli~itih mehanizama suo~avanja na depre-
siju, anksioznost, kognitivnu disfunkciju i umor, izuzev utjecaja na fizi~ko stanje. Prediktori koji smanjuju navedena
stanja su pozitivna reinterpretacija, humor i emocionalna socijalna potpora. Prediktori koji pogor{avaju navedena sta-
nja su planiranje, prihva}anje i negiranje. Provedenim istra`ivanjem uspjeli smo dokazati da je stopa psihijatrijskog
komorbiditeta u oboljelih od multiple skleroze zna~ajna te da razli~iti mehanizmi suo~avanja mogu pridonijeti, ali i
ote`ati, postizanje psihofizi~kog boljitka. Tako|er, pokazali smo da je umor zna~ajan ~imbenik bolesti i da se pozitivnim
mehanizmima suo~avanja mo`e umanjiti.
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